Richard B. Mailman
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
dopamine neuropharmacologyWebsite:
http://www.med.unc.edu/psych/directories/mailman.htmGoogle:
"Richard Mailman"Mean distance: 17.08 (cluster 6)
Children
Sign in to add trainee| Amy K. Jassen | grad student | 2003 | UNC Chapel Hill |
| Sarah K. Leonard | grad student | 2004 | UNC Chapel Hill |
| Karen L. Neitzel | grad student | 2004 | UNC Chapel Hill |
| Jessica P. Ryman | grad student | 2004 | UNC Chapel Hill |
| Scott H. Oloff | grad student | 2005 | UNC Chapel Hill |
| Justin C. Fowler | grad student | 2006 | UNC Chapel Hill |
| Jonathan D. Urban | grad student | 2006 | UNC Chapel Hill |
| Justin T. Brown | grad student | 2008 | UNC Chapel Hill |
| Thomas J. Walsh | post-doc | 1980-1986 | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cimino JX, Zhou M, Waxmonsky J, et al. (2023) Characterization of behavioral changes in T-maze alternation from dopamine D agonists with different receptor coupling mechanisms. Psychopharmacology |
| Yang Y, Lewis MM, Huang X, et al. (2022) Dopamine D receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiology. The International Journal of Biochemistry & Cell Biology. 148: 106235 |
| Yang Y, Lewis MM, Kong L, et al. (2022) A dopamine D agonist vs. methylphenidate in modulating prefrontal cortical working memory. The Journal of Pharmacology and Experimental Therapeutics |
| Weissenrieder JS, Reed JL, Moldovan GL, et al. (2021) Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D receptor-dependent, manner. Pharmacology Research & Perspectives. 9: e00689 |
| Mailman RB, Yang Y, Huang X. (2020) For Publication in The European Journal of Pharmacology D, not D, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa. European Journal of Pharmacology. 173760 |
| Huang X, Lewis MM, Van Scoy LJ, et al. (2020) The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. Journal of Parkinson's Disease |
| Yang Y, Mailman RB. (2020) Dopamine D 1 Agonists, Working Memory, and the Prefrontal Cortex: Effect of Receptor Functional Selectivity/Signaling Bias The Faseb Journal. 34: 1-1 |
| Weissenrieder JS, Neighbors JD, Mailman RB, et al. (2019) Cancer and the dopamine D2 receptor: a pharmacological perspective. The Journal of Pharmacology and Experimental Therapeutics |
| Yang Y, Lee SM, Imamura F, et al. (2018) D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex. Molecular Psychiatry |
| Baladi MG, Forster MJ, Gatch MB, et al. (2018) Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor. The Journal of Pharmacology and Experimental Therapeutics |